Gyuris Jeno 4
4 · AVEO PHARMACEUTICALS INC · Filed Mar 2, 2012
Insider Transaction Report
Form 4
Gyuris Jeno
SVP, Head of Research
Transactions
- Sale
Common Stock
2012-03-01$13.33/sh−2,000$26,660→ 88,612 total - Sale
Common Stock
2012-03-02$13.16/sh−2,100$27,636→ 86,512 total - Sale
Common Stock
2012-02-29$13.18/sh−1,000$13,175→ 90,612 total
Footnotes (3)
- [F1]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $13.10 to $13.25 per share. The reporting person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- [F2]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $13.32 to $13.34 per share. The reporting person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- [F3]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $13.16 to $13.20 per share. The reporting person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.